{"id":80868,"date":"2025-10-23T16:43:56","date_gmt":"2025-10-23T13:43:56","guid":{"rendered":"https:\/\/www.nationalturk.com\/en\/?p=80868"},"modified":"2025-10-23T16:43:56","modified_gmt":"2025-10-23T13:43:56","slug":"mrna-vaccine-advanced-cancer-patients","status":"publish","type":"post","link":"https:\/\/www.nationalturk.com\/en\/mrna-vaccine-advanced-cancer-patients\/","title":{"rendered":"COVID-19 mRNA vaccine may extend survival in advanced cancer patients"},"content":{"rendered":"

Vaccines are typically known for preventing disease \u2014 not treating it \u2014 but new research challenges that assumption. A recent U.S. study revealed that the COVID-19 mRNA vaccine appears to boost survival among advanced cancer patients undergoing immunotherapy. Scientists believe that if the results are validated in larger clinical trials, the discovery could redefine how cancer is treated in the future.<\/p>\n

Study details<\/strong><\/h3>\n

Researchers at the University of Texas MD Anderson Cancer Center analyzed data from more than 1,000 patients with advanced lung and skin cancers. They compared those who received an mRNA COVID-19 vaccine within 100 days of starting immunotherapy with those who did not.<\/p>\n

The results were striking:<\/strong><\/p>\n

Lung cancer patients who were vaccinated lived an average of 37.3 months, compared to 20.6 months for those who were not.<\/p>\n

Advanced melanoma patients saw survival increase from 26.7 months to up to 40 months among those who received the vaccine.<\/p>\n

Some participants were still alive when the data was collected, suggesting that the benefits may be even greater over time.<\/p>\n

Why mRNA vaccines stand out<\/strong><\/h2>\n

Researchers found no similar benefit from traditional flu or pneumonia vaccines, underscoring that mRNA vaccines<\/a> function differently.<\/p>\n

Unlike conventional vaccines, mRNA vaccines work by instructing human cells to produce a harmless piece of a virus \u2014 such as the coronavirus spike protein \u2014 that triggers a powerful immune response without causing infection.<\/p>\n

How vaccination may enhance cancer treatment<\/strong><\/h3>\n

Study coauthor Dr. Elias Sayour explained that mRNA vaccines may \u201csound the alarm\u201d within the immune system, helping it better recognize and attack cancer cells.<\/p>\n

Dr. Nilesh Vora described the effect as an \u201cenhancement\u201d that amplifies the response of immunotherapy.<\/p>\n

Lead author Dr. Adam Grippin said mRNA vaccines act \u201clike a siren\u201d that activates the immune system and, when combined with immune checkpoint inhibitors, unleashes its full potential to destroy tumors.<\/p>\n

\"\"<\/p>\n

A glimpse into the future of cancer vaccines<\/strong><\/h2>\n

Experts believe this research could pave the way for new types of mRNA-based cancer vaccines \u2014 ones that train the body to fight specific tumors.<\/p>\n

Dr. Tanya Evans said, \u201cInstead of providing instructions to make a viral spike protein, future vaccines could encode antigens from cancer cells, prompting the immune system to attack the tumor directly.\u201d<\/p>\n

Next steps<\/strong><\/h3>\n

Because the study was retrospective, researchers are now preparing a phase 3 clinical trial to confirm the findings in a controlled setting.<\/p>\n

\u201cOur hope is that RNA therapeutics could not only help patients already receiving immunotherapy but also benefit those with immune-resistant tumors,\u201d said Dr. Grippin.
\n